| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |